DongKoo Bio & Pharma Co. Ltd. (006620) - Total Liabilities

Latest as of June 2026: ₩176.02 Billion KRW ≈ $119.29 Million USD

Based on the latest financial reports, DongKoo Bio & Pharma Co. Ltd. (006620) has total liabilities worth ₩176.02 Billion KRW (≈ $119.29 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore long-term investment intensity of DongKoo Bio & Pharma Co. Ltd. to see how much of total assets are deployed in long-term investments.

DongKoo Bio & Pharma Co. Ltd. - Total Liabilities Trend (2015–2025)

This chart illustrates how DongKoo Bio & Pharma Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see DongKoo Bio & Pharma Co. Ltd. total assets.

DongKoo Bio & Pharma Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of DongKoo Bio & Pharma Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Fold Holdings, Inc. Class A Common Stock NASDAQ:FLD	USA	$41.98 Million
Gryphon Digital Mining Inc. NASDAQ:GRYP	USA	$17.19 Million
Is Girisim Sermayesi Yatirim Ortakligi AS IS:ISGSY	Turkey	TL4.03 Million
CESSATECH A/S DK -20 F:8GN	Germany	€1.38 Million
Rig Tenders Tbk JK:RIGS	Indonesia	Rp17.15 Billion
Nissan TA:NISA	Israel	ILA338.95 Million
Microba Life Sciences Ltd AU:MAP	Australia	AU$12.27 Million
Honey Badger Silver Inc V:TUF	Canada	CA$791.94K

Liability Composition Analysis (2015–2025)

This chart breaks down DongKoo Bio & Pharma Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DongKoo Bio & Pharma Co. Ltd. net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.90	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.55	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DongKoo Bio & Pharma Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DongKoo Bio & Pharma Co. Ltd. (2015–2025)

The table below shows the annual total liabilities of DongKoo Bio & Pharma Co. Ltd. from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩184.19 Billion ≈ $124.82 Million	+32.77%
2024-12-31	₩138.73 Billion ≈ $94.01 Million	+72.00%
2023-12-31	₩80.66 Billion ≈ $54.66 Million	+15.30%
2022-12-31	₩69.95 Billion ≈ $47.41 Million	+27.97%
2021-12-31	₩54.66 Billion ≈ $37.04 Million	+9.98%
2020-12-31	₩49.70 Billion ≈ $33.68 Million	+5.58%
2019-12-31	₩47.07 Billion ≈ $31.90 Million	+46.28%
2018-12-31	₩32.18 Billion ≈ $21.81 Million	-14.97%
2017-12-31	₩37.85 Billion ≈ $25.65 Million	-12.52%
2016-12-31	₩43.27 Billion ≈ $29.32 Million	-25.69%
2015-12-31	₩58.22 Billion ≈ $39.46 Million	--

About DongKoo Bio & Pharma Co. Ltd.

KQ:006620 Korea Pharmaceuticals

Market Cap

$22.84 Million

₩33.71 Billion KRW

Market Cap Rank

#24777 Global

#1784 in Korea

Share Price

₩3510.00

Change (1 day)

+0.57%

52-Week Range

₩3450.00 - ₩6090.00

All Time High

₩13745.55